Methods and compositions for treating or preventing symptoms of hormonal variations

Details for Australian Patent Application No. 2011223807 (hide)

Owner Fervent Pharmaceuticals, LLC

Inventors Royster Jr., George E.

Agent Freehills

Pub. Number AU-A-2011223807

PCT Pub. Number WO2011/109367

Priority 61/309,638 02.03.10 US

Filing date 1 March 2011

Wipo publication date 9 September 2011

International Classifications

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 9/70 Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 9/72 Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/38 - having sulfur as a ring hetero atom

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/554 - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61P 5/00 Drugs for disorders of the endocrine system

A61P 15/12 Drugs for genital or sexual disorders

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/109367 Priority application(s): WO2011/109367

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223816-Amorphous chewing gum bulk material

2011223805-Concentrated protein formulations and uses thereof